Gentamicin 1-5 mg/kg was injected into 14 anaesthetised cats in the presence of a constant, partial, non-depolarizing neuromuscular block. Twitch response in tibialis anterior was significantly depressed from 83% to 71% of control by a dose of 1.0 mg/kg. In soleus the same dose reduced twitch response from 76% to 71%. After a cumulative dose of 10 mg/kg twitch response in tibialis anterior and soleus was 34 % and 37% of control respectively. Calcium chloride 20 mg/kg restored twitch response to 66% in both muscles. Smaller doses of calcium chloride caused partial reversal which was maintained for five minutes in only 50% of instances.
INTRODUCTION
Since prolonged apnoea associated with neomycin was first reported by Pridgen I in 1956, there has been considerable interest in the neuromuscular blockade caused by aminoglycosides and other antibiotics. 2, 3 Experimentally, gentamicin is not the most potent of the aminoglycosides in this regard,4 and clinical reports implicating this drug 5 -7 are infrequent. Nevertheless, gentamicin is widely prescribed in patients undergoing surgery and its action at the neuromuscular junction i~ therefore of practical importance.
Investigations in the cat demonstrate significant neuromuscular blockade by gentamicin in the dose range 10-30 mg/kg. 8 • 9 The effect is also documented in vitro. 8 • 4 • 1O The dose range in vivo was well above that used in man, and the concentrations studied in vitro were in excess of human therapeutic blood levels. We therefore conclude that clinical problems will arise only when neuromuscular transmission is already compromised by other factors, such as the presence of neuromuscular blocking drugs.
We investigated the effect of small doses of gentamicin (1-10 mg/kg intravenously) on a constant non-depolarizing block in the cat. The actions of calcium and neostigmine on the combined gentamicin-curare block were also demonstrated. METHODS Fourteen adult cats of either sex were anaesthetised by intraperitoneal injection of chloralose (80 mg/kg) and sodium pentobarbitone (5 mg/kg). Ventilation through a tracheostomy was controlled using a Starling pump delivering air in a tidal volume of approximately 8 mllkg at a rate of 20 breaths/minute to maintain arterial Pco, in the range 25-35 mmHg.
The tibia and femur of one leg were held rigid by bone pins, and the tendons of tibialis anterior (white, fast-contracting) and soleus (red, slow-contracting) muscles connected to Grass FT03C force transducers with a resting tension of 50 g. The ipsilateral sciatic nerve was divided and the distal portion stimulated at 0.06 Hz with a single square-wave impulse of 0.2 ms duration, at a voltage at least 500/0 greater than that required to give a maximal response. Twitch height was recorded on a Beckman RB Dynograph. Arterial blood pressure was measured using a carotid artery cannula and a Statham P23DC pressure transducer. Heart rate was tabulated from direct counts of pressure deflections on the Dynograph. d-tubocurarine (Tubarine, Burroughs Wellcome, Australia) was infused through a cannula in a jugular vein using a motorised syringe pump. Another cannula was placed in a femoral vein for bolus injections of drugs and fluids. Intravenous fluid (40/0 dextrose 0.2% saline) was given at 5 mllkg/hour until the commencement of the curare infusion, the latter providing approximately 30 mllhour. Body heat was conserved by insulation and provision of a heated bench, radiant heat, and warmed intravenous fluids. Rectal temperature was measured hourly. Arterial blood gases and serum electrolytes, urea and creatinine were measured before and after the experimental period.
In all 14 cats a partial neuromuscular blockade was achieved with d-tubocurarine. A bolus dose of 200 /-lg/kg was followed by an infusion, the rate being adjusted to produce a constant block of 75-85% of control twitch height in tibialis anterior. The infusion rate to achieve constant block varied from 2-10 /-lg/kg/min in different cats. This infusion was continued throughout the experiment. The investigation was conducted in three groups. GROUP A: In six cats gentamicin sulphate (Garamycin, Schering Corp., U.S.A., 0.568 mg base/mg) in a dose of 1, 4 and 5 mg/kg was given at five minute intervals, followed by calcium chloride (20 mg/kg) and neostigmine (Prostigmin, Roche) (50 /-lg/kg), also at five minute intervals. Gentamicin weight is expressed as the total salt. GROUP B: In four cats one dose of gentamicin (5 mg/kg) was given, followed 15 minutes later by calcium chloride in doses of 5, 5 and 10 mg/kg at five minute intervals. GROUP C: A further four cats were investigated as in Group B but in addition, Anaesthesia and Intensive Care, Va!. VIII, No. I, February. 1980 calcium chloride (5 mg/kg) was given both before and during the curare infusion, prior to the injection of gentamicin. After each injection of calcium chloride, the twitch height was allowed to re-establish a steady state during 10-15 minutes before the next manoeuvre.
Statistical analysis was performed using the paired Student t test comparing means before and after each drug.
RESULTS
Twitch height response to gentamicin (Group A). During the constant infusion, the mean twitch height in tibialis anterior was 83 % of the control ( Table 1 ). The partial block in soleus at the same time was 76%. Gentamicin 1.0 mg/kg produced in tibialis anterior a significant decrease of 12% in twitch height within one minute. Incremental doses of 4 and 5 mg/kg resulted in further depression of muscle contraction by 21 % and 16% respectively. In soleus, the lowest dose of gentamicin (1.0 mg/kg) depressed twitch height by 4%, which was not statistically significant. However, there was a significant depression of twitch height by 17% after both the 4 and 5 mg/kg doses. Depression was maximal within one minute in both tibialis anterior and soleus. On some occasions, contraction height increased over the next four minutes.
After a total cumulative gentamicin dose of 10 mg/kg, calcium chloride (20 mg/kg) resulted in an increase to 66% of control twitch height in both muscles. However, the block was still greater than that due to curare infusion alone ( Table 1 ). The response to calcium was maximal within 2-3 minutes, but was only transient in some animals. Neostigmine (50 /-lg/kg) increased twitch height significantly in tibialis anterior (to 108%). In soleus, there was also an increase (to 88%), but this was not statistically significant.
The effect of incremental calcium on combined curare-gentamicin block (Groups B and C). In all eight cats the response to gentamicin 5 mg/kg was maximal within one minute. Over the subsequent 15 minutes the degree of block in tibialis anterior was maintained in only four of the eight cats, and in soleus three of the eight ( Table 3) . Maintenance of the block in each muscle type varied within the same animal and also between different animals. In both groups Band C the first dose of calcium chloride (5 mg/kg) following the gentamicin caused significant increases in twitch height in both tibialis anterior and soleus, 19070 and 10% respectively ( Table 2) . However, in tibialis anterior this increase was maintained for less than five minutes in four of the eight cats (Table 3 ). In tibialis anterior, additional doses of calcium chloride further increased twitch response to a maximum of 71 % after a cumulative dose of 20 mg/kg. This was similar to the finding in Group A (Table 1) . In soleus however, further calcium did not significantly diminish the block. In several animals the degree of block increased.
In tibialis anterior, calcium chloride given prior to curare (Group C, Table 2 ) produced a significant decrease (8 %) in contraction height but this returned towards control after five minutes. In soleus the decrease in twitch height was not significant, one animal showing no change. The dose of calcium (5 mg/kg) given after the establishment of the curare block did not significantly alter twitch height in either muscle ( Table 2 ).
Cardiovascular Effects
The bolus dose of curare decreased mean systolic and diastolic blood pressures from 117/75 to 93/46 ( Table 4 ). The cumulative dose of gentamicin (10 mg/kg) depressed blood pressure from 115/81 to 99/61. Calcium chloride (20 mg/kg) raised the blood pressure from 99/61 to 126/85. Gentamicin and calcium chloride did not significantly alter pulse rate. There were no significant changes in any of the parameters measured during the experiment ( Table 5 ).
DISCUSSION
In the presence of a partial non-depolarizing block gentamicin consistently depressed muscle contraction in all cats. This action was dosedependent and occurred in both muscle types. In tibialis anterior an effect was produced at a dose of 1.0 mg/kg, which is therapeutic in man. Neuromuscular blockade at such a low dose of gentamicin, with or without accompanying non-depolarizing blockade, has not previously been reported.
It is known that in the course of a nondepolarizing block about 80070 of postjunctional receptors must be occupied before neuromuscular transmission shows impairment. ll Thus a partial non-depolarizing block places the receptor population in a critical balance and may unmask the otherwise weak blocking action of another drug. This interaction has been demonstrated with gentamicin,8 neomycin, 12 and amikacin. 13 These workers studied the action of the antibiotic during recovery from non-depolarizing block caused by a bolus injection of relaxant. In contrast, the present study was designed to examine the effect of gentamicin on a stable, partial, non-depolarizing block in order that was of shorter duration. In tibialis anterior, calcium given before curare significantly decreased twitch height but tended to increase it after curare. These effects were not seen in soleus.
The effect of gentamicin was consistently greater in tibialis anterior than in soleus. This is in accord with observations made by Adams et al. 9 in 1976. There were also differences in the response of the combined block to repeated doses of calcium. However, it is known that fast-and slow-contracting muscles differ in sensitivity to both depolarizing and nondepolarizing relaxants. These differences in response may be important clinically, particularly with respect to blockade and recovery in respiratory muscles. CONCLUSION Gentamicin in the therapeutic dose of 1.0 mg/kg can enhance a non-depolarizing block in the cat. This interaction may occur in anaesthetic practice more commonly than is supposed, especially when the margin of safety of neuromuscular transmission is reduced by other factors. We suggest that if a patient undergoing relaxant anaesthesia requires intravenous gentamicin, this should be given as early as practicable before reversal is attempted. If reversal by an anti-cholinesterase is unsatisfactory and gentamicin is implicated then calcium may reasonably be given. The effect of calcium may be shorter-lived than the effect of gentamicin.
